# Commission Regulation (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, Division 1.2.4

Extent: E+W+S+N.I.

Macrolides
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
Other provisions
Spiramycin
Sum of spiramycin and neospiramycin
Bovine
200 μg/kg
Muscle
300 μg/kg
Fat
300 μg/kg
Liver
300 μg/kg
Kidney
200 μg/kg
Milk
Chicken
200 μg/kg
Muscle
300 μg/kg
Skin and fat
400 μg/kg
Liver
Tilmicosin
Tilmicosin
Bovine, ovine, porcine
50 μg/kg
Muscle
50 μg/kg
Fat
1 000 μg/kg
Liver
1 000 μg/kg
Kidney
Ovine
50 μg/kg
Milk
Chicken
75 μg/kg
Muscle
Not for use in animals from which eggs are produced for human consumption
75 μg/kg
Skin and fat
1 000 μg/kg
Liver
250 μg/kg
Kidney
Tylosin
Tylosin A
Bovine
100 μg/kg
Muscle
100 μg/kg
Fat
100 μg/kg
Liver
100 μg/kg
Kidney
50 μg/kg
Milk
Porcine
100 μg/kg
Muscle
100 μg/kg
Skin and fat
100 μg/kg
Liver
100 μg/kg
Kidney
Poultry
100 μg/kg
Muscle
Not for use in hens producing eggs for human consumption
100 μg/kg
Skin and fat
100 μg/kg
Liver
100 μg/kg
Kidney

---
Source: https://www.legislation.gov.uk/eur/1999/508/annex/I/division/1/division/1.2/division/1.2.4 (the official version)
Page: https://openlegislation.uk/eu-regulation-1999-508/annex-I/division-1/division-1.2/division-1.2.4
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.